Overcoming the Stratum Corneum: The Modulation of Skin Penetration

It is preferred that topically administered drugs act either dermally or transdermally. For that reason they have to penetrate into the deeper skin layers or permeate the skin. The outermost layer of the human skin, the stratum corneum, is responsible for its barrier function. Most topically administered drugs do not have the ability to penetrate the stratum corneum. In these cases modulations of the skin penetration profiles of these drugs and skin barrier manipulations are necessary. A skin penetration enhancement can be achieved either chemically, physically or by use of appropriate formulations. Numerous chemical compounds have been evaluated for penetration-enhancing activity, and different modes of action have been identified for skin penetration enhancement. In addition to chemical methods, skin penetration of drugs can be improved by physical options such as iontophoresis and phonophoresis, as well as by combinations of both chemical and physical methods or by combinations of several physical methods. There are cases where skin penetration of the drug used in the formulation is not the aim of the topical administration. Penetration reducers can be used to prevent chemicals entering the systemic circulation. This article concentrates on the progress made mainly over the last decade by use of chemical penetration enhancers. The different action modes of these substances are explained, including the basic principles of the physical skin penetration enhancement techniques and examples for their application.

[1]  Rainer H. Müller,et al.  Transdermal Delivery of Highly Lipophilic Drugs: In Vitro Fluxes of Antiestrogens, Permeation Enhancers, and Solvents from Liquid Formulations , 2002, Pharmaceutical Research.

[2]  M. Yazdanian,et al.  The effect of diethylene glycol monoethyl ether as a vehicle for topical delivery of ivermectin , 2005, Veterinary Research Communications.

[3]  B. Forslind A domain mosaic model of the skin barrier. , 1994, Acta dermato-venereologica.

[4]  A. Tedesco,et al.  Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Y. Chien,et al.  Transdermal Controlled Administration of Indomethacin. I. Enhancement of Skin Permeability , 1988, Pharmaceutical Research.

[6]  M. Bentley,et al.  Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  R. Neubert,et al.  [Modulation of drug penetration in the skin]. , 1996, Die Pharmazie.

[8]  Sang-Chul Shin,et al.  Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  J Kost,et al.  Low‐Frequency Sonophoresis: A Noninvasive Method of Drug Delivery and Diagnostics , 2000, Biotechnology progress.

[10]  K. Sugibayashi,et al.  Effect of monoglycerides on the percutaneous absorption of papaverine hydrochloride. , 1990, Drug design and delivery.

[11]  M. Roberts,et al.  Veterinary drug delivery: potential for skin penetration enhancement. , 2001, Advanced drug delivery reviews.

[12]  P. Corti,et al.  Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  J. Weitzman,et al.  Skin deep , 2003, Genome Biology.

[14]  W. Sterry,et al.  Penetration von Mikropartikeln in die menschliche Haut , 2004, Der Hautarzt.

[15]  B. W. Barry,et al.  Drug delivery routes in skin: a novel approach. , 2002, Advanced drug delivery reviews.

[16]  Y. Kalia,et al.  Iontophoretic Transport across the Skin , 2001, Skin Pharmacology and Physiology.

[17]  M. Nakano,et al.  Evaluation of percutaneous absorption of midazolam by terpenes. , 2003, Drug metabolism and pharmacokinetics.

[18]  J. Lademann,et al.  [Follicular penetration. An important pathway for topically applied substances]. , 2003, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[19]  Banerjee Pk,et al.  Topical urea in dermatology. , 1990 .

[20]  J. Chapman,et al.  Facilitated transport of two model steroids by esters and amides of clofibric acid. , 1993, Journal of pharmaceutical sciences.

[21]  B. Tashtoush,et al.  Azathioprine transport through rat skin and its immunosuppressive effect. , 2004, Die Pharmazie.

[22]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[23]  José Juan Escobar-Chávez,et al.  In Vivo Skin Permeation of Sodium Naproxen Formulated in Pluronic F-127 Gels: Effect of Azone® and Transcutol® , 2005, Drug development and industrial pharmacy.

[24]  D. Paolino,et al.  Biomembrane Model Interaction and Percutaneous Absorption of Papaverine Through rat Skin: Effects of Cyclodextrins as Penetration Enhancers , 2001, Journal of drug targeting.

[25]  Lokesh Joshi,et al.  Comparative Study of the Skin Penetration of Protein Transduction Domains and a Conjugated Peptide , 2005, Pharmaceutical Research.

[26]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[27]  J. Lademann,et al.  The role of follicular penetration. A differential view. , 2001, Skin pharmacology and applied skin physiology.

[28]  M. Fujii,et al.  Enhancement Effect of p‐Menthane‐3,8‐diol on In Vitro Permeation of Antipyrine and Indomethacin Through Yucatan Micropig Skin , 2004, Drug development and industrial pharmacy.

[29]  Taravat Ghafourian,et al.  The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[30]  B. W. Barry,et al.  Transdermal permeation modulation by cyclodextrins: a mechanistic study. , 1998, Pharmaceutical development and technology.

[31]  K. Uekama,et al.  Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl‐ethyl‐β‐cyclodextrin and penetration enhancers , 1992, The Journal of pharmacy and pharmacology.

[32]  D. Friend Transdermal delivery of levonorgestrel , 1991, Medicinal research reviews.

[33]  L. Norlén,et al.  Skin barrier structure and function: the single gel phase model. , 2001, The Journal of investigative dermatology.

[34]  N. He,et al.  Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers. , 2005, International journal of pharmaceutics.

[35]  P. Elsner,et al.  Skin roughness is negatively correlated to irritation with DMSO, but not with NaOH and SLS , 1997, Experimental dermatology.

[36]  Thiele Jj Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. , 2001 .

[37]  J. H. Rytting,et al.  New Alkyl N,N-Dialkyl-Substituted Amino Acetates as Transdermal Penetration Enhancers , 1989, Pharmaceutical Research.

[38]  R. Langer,et al.  Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. , 2005, Journal of pharmaceutical sciences.

[39]  Hoo-Kyun Choi,et al.  Effects of Vehicles and Pressure Sensitive Adhesives on the Penetration of Isosorbide Dinitrate Across the Hairless Mouse Skin , 2002, Drug delivery.

[40]  J. Pandit,et al.  Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. , 2004, International journal of pharmaceutics.

[41]  S. Mitragotri,et al.  Low-frequency sonophoresis: a review. , 2004, Advanced drug delivery reviews.

[42]  J. Lademann,et al.  Follikuläre Penetration , 2003, Der Hautarzt.

[43]  M. Player,et al.  Synthesis and in vitro transdermal penetration enhancing activity of lactam N-acetic acid esters. , 1996, Journal of pharmaceutical sciences.

[44]  Y. Kalia,et al.  Passive skin penetration enhancement and its quantification in vitro. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  J. Hadgraft,et al.  The Relative Effect of Azone® and Transcutol® on Permeant Diffusivity and Solubility in Human Stratum Corneum , 1996, Pharmaceutical Research.

[46]  P. Paronen,et al.  Dodecyl N,N-Dimethylamino Acetate and Azone Enhance Drug Penetration Across Human, Snake, and Rabbit Skin , 1991, Pharmaceutical Research.

[47]  S. Güngör,et al.  Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin. , 2004, Die Pharmazie.

[48]  S. Santoyo,et al.  Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[49]  B. Mukherjee,et al.  Sorbitan Monolaurate 20 as a Potential Skin Permeation Enhancer in Transdermal Patches , 2005 .

[50]  H. Gwak,et al.  Transdermal Delivery of Ketorolac Tromethamine: Effects of Vehicles and Penetration Enhancers , 2004, Drug development and industrial pharmacy.

[51]  B. Forbes,et al.  The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. , 2005, International journal of pharmaceutics.

[52]  R. Neubert,et al.  Modulation der Wirkstoffpenetration in die Haut , 1996 .

[53]  Samir Mitragotri,et al.  Synergistic Effect of Enhancers for Transdermal Drug Delivery , 2000, Pharmaceutical Research.

[54]  Lasse Murtomäki,et al.  Electrochemical Characterization of Human Skin by Impedance Spectroscopy: The Effect of Penetration Enhancers , 1993, Pharmaceutical Research.

[55]  I. Oh,et al.  Development of tretinoin gels for enhanced transdermal delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  V. Satyanarayana,et al.  Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[57]  K. Svendsen,et al.  Irritant cutaneous reactions to N‐methyl‐2‐pyrrolidone (NMP) , 1992, Contact dermatitis.

[58]  C. Valenta,et al.  Effects of Penetration Enhancers on the In‐vitro Percutaneous Absorption of Progesterone , 1997, The Journal of pharmacy and pharmacology.

[59]  Effect of cetrimide and ascorbic acid on in vitro human skin permeation of haloperidol. , 2001, Chemical & pharmaceutical bulletin.

[60]  M. Fujii,et al.  Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone. , 2000, Biological & pharmaceutical bulletin.

[61]  Dennis K. Lee,et al.  Percutaneous Absorption Enhancement of Leuprolide , 1992, Pharmaceutical Research.

[62]  H. Drexler,et al.  In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents , 2003, International archives of occupational and environmental health.

[63]  Seung Hun Lee,et al.  The Pretreatment Effect of Chemical Skin Penetration Enhancers in Transdermal Drug Delivery Using Iontophoresis , 1999, Skin Pharmacology and Physiology.

[64]  T. Higuchi,et al.  Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers I: Synthesis. , 1988, Journal of Pharmacy and Science.

[65]  Adrian C. Williams,et al.  Penetration enhancers. , 2004, Advanced drug delivery reviews.

[66]  B. Michniak,et al.  Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. , 1999, Drug development and industrial pharmacy.

[67]  R. Neubert,et al.  Neuere Entwicklungen auf dem Gebiet der dermalen Wirkstoffapplikation , 1998 .

[68]  J. Hadgraft,et al.  Modulation of the Barrier Function of the Skin , 2001, Skin Pharmacology and Physiology.

[69]  Eric W. Smith,et al.  The role of percutaneous penetration enhancers , 1996 .

[70]  J. Hadgraft Skin, the final frontier. , 2001, International journal of pharmaceutics.

[71]  P. K. Banerjee,et al.  Topical urea in dermatology. , 1990, Indian journal of dermatology.

[72]  J. Thiele Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. , 2001, Skin pharmacology and applied skin physiology.

[73]  S. Spruance,et al.  Failure of topical acyclovir in ointment to penetrate human skin , 1986, Antimicrobial Agents and Chemotherapy.

[74]  Z. Ying,et al.  Preparation, Evaluation, and NMR Characterization of Vinpocetine Microemulsion for Transdermal Delivery , 2004, Drug development and industrial pharmacy.

[75]  S. Chan,et al.  Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum. , 2003, Biological & pharmaceutical bulletin.

[76]  R. Neubert,et al.  Evaluation of drug penetration into human skin ex vivo using branched fatty acids and propylene glycol , 1996 .

[77]  Samir Mitragotri,et al.  Discovery of transdermal penetration enhancers by high-throughput screening , 2004, Nature Biotechnology.

[78]  K. Creek,et al.  Evaluation of transdermal penetration enhancers using a novel skin alternative. , 1997, Journal of pharmaceutical sciences.

[79]  Samir Mitragotri,et al.  Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.

[80]  A. Sintov,et al.  Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[81]  J. Pandit,et al.  Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. , 2005, International journal of pharmaceutics.

[82]  R. Neubert,et al.  [Fatty acids and the epidermis]. , 1997, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[83]  F. Hamel,et al.  A combination of iontophoresis and the chelating agent 1, 10 phenanthroline act synergistically as penetration enhancers , 2000, AAPS PharmSci.

[84]  T. Hwang,et al.  Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery. , 2004, Biological & pharmaceutical bulletin.

[85]  Bozena Michniak,et al.  Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[86]  T. Nagai,et al.  Thiomenthol derivatives as novel percutaneous absorption enhancers. , 1999, Drug development and industrial pharmacy.

[87]  L. Strekowski,,et al.  Investigation of Iminosulfuranes as Novel Transdermal Penetration Enhancers: Enhancement Activity and Cytotoxicity , 2005, Pharmaceutical Research.

[88]  Massimiliano Nino,et al.  Intradermal drug delivery by low-frequency sonophoresis (25 kHz). , 2004, Dermatology online journal.

[89]  A. Wolka,et al.  The interaction of the penetration enhancer DDAIP with a phospholipid model membrane. , 2004, International journal of pharmaceutics.

[90]  P. Wertz,et al.  Lipids and barrier function of the skin. , 2000, Acta dermato-venereologica. Supplementum.

[91]  Y. Kalia,et al.  Effects of Sucrose Oleate and Sucrose Laureate on in Vivo Human Stratum Corneum Permeability , 2003, Pharmaceutical Research.

[92]  Shao Jun Jiang,et al.  Examination of the mechanism of oleic acid-induced percutaneous penetration enhancement: an ultrastructural study. , 2003, Biological & pharmaceutical bulletin.

[93]  Jagdish Singh,et al.  Effect of Chemical Penetration Enhancer and Iontophoresis on the In Vitro Percutaneous Absorption Enhancement of Insulin Through Porcine Epidermis , 2005, Pharmaceutical development and technology.

[94]  J. Lademann,et al.  [Penetration of microparticles into human skin]. , 2004, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[95]  B. Wilffert,et al.  A Study of the Percutaneous Absorption‐enhancing Effects of Cyclodextrin Derivatives in Rats , 1994, The Journal of pharmacy and pharmacology.

[96]  G. Piérard,et al.  Penetration Enhancers Assessed by Corneoxenometry , 2000, Skin Pharmacology and Physiology.

[97]  O. Pillai,et al.  Transdermal Iontophoresis of Insulin , 2004, Skin Pharmacology and Physiology.

[98]  M. Herráez,et al.  In vitro percutaneous penetration of acyclovir from solvent systems and Carbopol 971-P hydrogels: influence of propylene glycol. , 2005, Journal of pharmaceutical sciences.

[99]  Samir Mitragotri,et al.  Design principles of chemical penetration enhancers for transdermal drug delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Y. Kalia,et al.  Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon. , 2005, International journal of pharmaceutics.

[101]  K. Audus,et al.  Effect of Some Penetration Enhancers on Epithelial Membrane Lipid Domains: Evidence from Fluorescence Spectroscopy Studies , 1994, Pharmaceutical Research.

[102]  L. Felton,et al.  Influence of Transcutol CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[103]  S. Mitragotri,et al.  Combined Effect of Low-Frequency Ultrasound and Iontophoresis: Applications for Transdermal Heparin Delivery , 2000, Pharmaceutical Research.

[104]  L. Norlén,et al.  Skin barrier formation: the membrane folding model. , 2001, The Journal of investigative dermatology.

[105]  D. Moore,et al.  Insights into the molecular organization of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. , 2000, Acta dermato-venereologica. Supplementum.

[106]  V. Rodilla,et al.  Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[107]  M. Fujii,et al.  Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[108]  J. Bouwstra,et al.  The lipid organisation in the skin barrier. , 2000, Acta dermato-venereologica. Supplementum.

[109]  Ruikang K. Wang,et al.  Comparing the synergistic effects of oleic acid and dimethyl sulfoxide as vehicles for optical clearing of skin tissue in vitro , 2004, Physics in medicine and biology.

[110]  A J Hopfinger,et al.  Characterization of skin penetration processes of organic molecules using molecular similarity and QSAR analysis. , 2004, Molecular pharmaceutics.

[111]  C. Cho,et al.  Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix. , 2004, International journal of pharmaceutics.

[112]  S. Tenjarla,et al.  Synthesis and evaluation of N-acetylprolinate esters - novel skin penetration enhancers. , 1999, International journal of pharmaceutics.